We are live on ! Find out more
JANX icon

Janux Therapeutics
JANX

44 hedge funds and large institutions have $318M invested in Janux Therapeutics in 2022 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 15 increasing their positions, 15 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

1.24% more ownership

Funds ownership: 68.21% → 69.45% (+1.2%)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0% more repeat investments, than reductions

Existing positions increased: 15 | Existing positions reduced: 15

6% less funds holding

Funds holding: 47 → 44 (-3)

22% less capital invested

Capital invested by funds: $407M → $318M (-$88.7M)

40% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 5

Holders
44
Holders Change
-3
Holders Change %
-6.38%
% of All Funds
0.74%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
3
Increased
15
Reduced
15
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
BI
BVF Inc
California
+$3.88M
2
Fidelity Investments
Fidelity Investments
Massachusetts
+$1.76M
3
JP Morgan Chase
JP Morgan Chase
New York
+$1.01M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$990K
5
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale
Germany
+$586K

Top Sellers

1
Janus Henderson Group
Janus Henderson Group
United Kingdom
-$2.5M
2
SB
Samsara BioCapital
California
-$609K
3
State of Wisconsin Investment Board
State of Wisconsin Investment Board
Wisconsin
-$254K
4
Bank of America
Bank of America
North Carolina
-$185K
5
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$165K
Name Holding Trade Value Shares
Change 		Change in
Stake
RCM
1
RA Capital Management
Massachusetts
$106M – – –
Fidelity Investments
2
Fidelity Investments
Massachusetts
$71.1M +$1.76M +148,778 +3%
Janus Henderson Group
3
Janus Henderson Group
United Kingdom
$26M -$2.5M -211,349 -9%
Citadel Advisors
4
Citadel Advisors
Florida
$22.6M – – –
BI
5
BVF Inc
California
$18M +$3.88M +327,994 +29%
EC
6
EcoR1 Capital
California
$17.4M – – –
BlackRock
7
BlackRock
New York
$14.8M +$552K +46,633 +4%
Vanguard Group
8
Vanguard Group
Pennsylvania
$7.93M +$990K +83,661 +15%
5VM
9
5AM Venture Management
California
$5.45M – – –
Adage Capital Partners
10
Adage Capital Partners
Massachusetts
$4.88M – – –
SB
11
Samsara BioCapital
California
$4.4M -$609K -51,457 -12%
WP
12
Woodline Partners
California
$3.5M +$95.4K +8,060 +3%
Geode Capital Management
13
Geode Capital Management
Massachusetts
$3.46M +$99.3K +8,389 +3%
State Street
14
State Street
Massachusetts
$3.22M +$261K +22,024 +9%
Cerity Partners
15
Cerity Partners
New York
$1.84M – – –
Northern Trust
16
Northern Trust
Illinois
$1.63M -$83.9K -7,090 -5%
JP Morgan Chase
17
JP Morgan Chase
New York
$1.26M +$1.01M +85,552 +477%
N
18
Nuveen
North Carolina
$915K +$583K +49,213 +192%
DekaBank Deutsche Girozentrale
19
DekaBank Deutsche Girozentrale
Germany
$566K +$586K +49,500 New
Charles Schwab
20
Charles Schwab
California
$520K -$22.4K -1,890 -4%
Bank of New York Mellon
21
Bank of New York Mellon
New York
$517K -$42.8K -3,615 -8%
PL
22
Parkwood LLC
Ohio
$412K +$65K +5,492 +19%
Wells Fargo
23
Wells Fargo
California
$362K +$295K +24,898 +525%
Morgan Stanley
24
Morgan Stanley
New York
$337K -$118 -10 -0%
Bank of America
25
Bank of America
North Carolina
$312K -$185K -15,641 -38%
1
2

JANX Hedge Fund Activity: Q2 2022 in Review

44 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Janux Therapeutics (JANX) for Q2 2022, worth a combined $318M — down 22% from $407M a quarter earlier.

Sellers outnumbered buyers: 5 funds closed out of JANX and 3 opened new positions — a net loss of 2 holders — while 15 trimmed existing stakes and 15 added.

The largest buyer was BVF Inc, adding an estimated $3.88M. The largest seller was Janus Henderson Group, cutting an estimated $2.5M.

  • 44 institutional investors held Janux Therapeutics (JANX) as of Q2 2022, down from 47 in Q1 2022.
  • Funds reported $318M of Janux Therapeutics stock for Q2 2022, down 22% quarter-over-quarter.
  • 3 funds opened new Janux Therapeutics positions in Q2 2022 and 5 closed out, a net change of -2 holders.
  • The largest Janux Therapeutics buyer in Q2 2022 was BVF Inc, an estimated $3.88M added.
  • The largest Janux Therapeutics seller in Q2 2022 was Janus Henderson Group, an estimated $2.5M sold.

Based on aggregated 13F filings for Q2 2022.